AlbertoMendivilMDFACOG, FACS
Obstetrics & Gynecology • Newport Beach, CAGynecologic Oncology
Co- Director , Hoag Gynecologic Oncology and Complex Pelvic Surgery
Dr. Mendivil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
351 Hospital Rd.
Suite 507
Newport Beach, CA 92663Phone+1 949-642-1361Fax+1 949-642-1394
Summary
- Specialist in the management of gynecologic malignancies, pre invasive disease , and complex benign Gynecologic diseases.
Education & Training
University of North Carolina HospitalsFellowship, Gynecologic Oncology, 2007 - 2010
University of California (Irvine)Residency, Obstetrics and Gynecology, 2003 - 2007- University of California (Irvine)Internship, Obstetrics and Gynecology, 2003 - 2004
University of Utah School of MedicineClass of 2003
University of California, San DiegoBS, Physiology and neurosciences, 1993 - 1998
Certifications & Licensure
CA State Medical License 2005 - 2027
NC State Medical License 2007 - 2010- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Practice Solution EMR, GE Healthcare, 2011-2012
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
- Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Start of enrollment: 2011 Jun 01
Publications & Presentations
PubMed
- 3 citationsA phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi
International Journal of Gynecological Cancer. 2023-09-04 - 9 citationsClinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer...Robert W Holloway, Alberto A Mendivil, James E Kendrick, Lisa N Abaid, John V Brown
JAMA Oncology. 2023-07-01 - 20 citationsThe MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes.Mario M Leitao Jr, Qin C Zhou, Benny Brandt, Alexia Iasonos, Vasileios Sioulas
Gynecologic Oncology. 2022-09-01
Press Mentions
Everything You Need to Know About HPV & the VaccineOctober 3rd, 2018
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
